We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$89.8B
AUM Growth
+$11.9B
Cap. Flow
-$2.77B
Cap. Flow %
-3.09%
Top 10 Hldgs %
9.11%
Holding
2,631
New
147
Increased
1,215
Reduced
1,097
Closed
95

Sector Composition

Rank Sector Weight
1 Technology 18.8%
2 Industrials 13.1%
3 Financials 12%
4 Healthcare 11.59%
5 Consumer Discretionary 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOVN
2476
DELISTED
Novan, Inc. Common Stock
NOVN
$18K ﹤0.01%
2,205
+173
+9% +$945
SENS icon
2477
Senseonics Holdings Inc
SENS
$366M
$17K ﹤0.01%
967
-358
-27% -$3.12K
TTI icon
2478
TETRA Technologies
TTI
$1.26B
$17K ﹤0.01%
19,205
+2,600
+16% +$1.78K
TYME
2479
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$15K ﹤0.01%
+11,994
New +$12.3K
XTNT icon
2480
Xtant Medical Holdings
XTNT
$62.3M
$14K ﹤0.01%
+11,951
New +$15.4K
TRAW icon
2481
Traws Pharma
TRAW
$8.1M
$14K ﹤0.01%
83
+7
+9% +$813
AUMN
2482
DELISTED
Golden Minerals Company
AUMN
$14K ﹤0.01%
751
+70
+10% +$912
RMTI icon
2483
Rockwell Medical
RMTI
$28.2M
$13K ﹤0.01%
115
+9
+8% +$1.01K
PEI
2484
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$12K ﹤0.01%
817
+42
+5% +$474
ASXC
2485
DELISTED
Asensus Surgical, Inc.
ASXC
$10K ﹤0.01%
15,398
+790
+5% +$361
CNVS icon
2486
Cineverse
CNVS
$65.6M
$9K ﹤0.01%
+696
New +$8.46K
JAGX icon
2487
Jaguar Health
JAGX
$4.67M
0
MMAT
2488
DELISTED
Meta Materials Inc. Common Stock
MMAT
$9K ﹤0.01%
67
+3
+5% +$234
CFMS
2489
DELISTED
Conformis, Inc. Common Stock
CFMS
$9K ﹤0.01%
547
+36
+7% +$621
REED
2490
DELISTED
Reeds, Inc. Common Stock
REED
$8K ﹤0.01%
+259
New +$10.1K
CATX icon
2491
Perspective Therapeutics
CATX
$342M
$7K ﹤0.01%
1,461
+386
+36% +$1.71K
DMK
2492
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$7K ﹤0.01%
215
+19
+10% +$845
ZSAN
2493
DELISTED
Zosano Pharma Corporation
ZSAN
$7K ﹤0.01%
378
+20
+6% +$391
ASRT
2494
DELISTED
Assertio
ASRT
$6K ﹤0.01%
266
+13
+5% +$404
INUV icon
2495
Inuvo
INUV
$17M
$6K ﹤0.01%
1,357
+54
+4% +$208
OGEN icon
2496
Oragenics
OGEN
$2.48M
$6K ﹤0.01%
+8
New +$7.04K
BIOL
2497
DELISTED
Biolase, Inc.
BIOL
$6K ﹤0.01%
6
AVGR
2498
DELISTED
Avinger, Inc. Common Stock
AVGR
$6K ﹤0.01%
46
+3
+7% +$272
XELA
2499
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$6K ﹤0.01%
1
GEN
2500
DELISTED
Genesis Healthcare, Inc.
GEN
$6K ﹤0.01%
11,456
+588
+5% +$297

Similar funds

Victory Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Victory Capital Management held 2,631 positions worth $89.8B, up 15% from $77.9B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Victory Capital Management withdrew a net $2.77B in Q4 2020, closing 95 positions and reducing 1,097 holdings. Its most notable exit was iShares MSCI EAFE Min Vol Factor ETF, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.

Against the trend, Victory Capital Management opened a new position in iShares 7-10 Year Treasury Bond ETF worth $61M.

  • Victory Capital Management's largest Q4 2020 buy was iShares 7-10 Year Treasury Bond ETF: 508,358 shares worth $61M.
  • Victory Capital Management added most to Victory Portfolios II VictoryShares Core Intermediate Bond ETF in Q4 2020, an estimated $169M increase.
  • Victory Capital Management's biggest Q4 2020 reduction was Public Storage, cutting an estimated $180M.
  • Victory Capital Management fully exited iShares MSCI EAFE Min Vol Factor ETF in Q4 2020, selling an estimated $121M.
  • Victory Capital Management's ten largest holdings make up 9.1% of its $89.8B portfolio in Q4 2020.
  • Victory Capital Management opened 147 new positions and closed 95 in Q4 2020.
  • Victory Capital Management's portfolio value rose 15% quarter-over-quarter to $89.8B.

Based on Victory Capital Management's 13F filing for Q4 2020, filed 1 Feb 2021.